„Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway“. Nigerian Journal of Physiological Sciences, sv. 40, izd. 2, prosinac 2025., str. 251-62, https://doi.org/10.54548/.